Core Scientific, Inc. — Form 8-K Summary
Business context and reporting period
Core Scientific, Inc. filed a Form 8-K dated August 11, 2022, relating to management’s conference call discussing financial results for the three and six months ended June 30, 2022. The company is a Delaware corporation headquartered in Austin, Texas, with common stock and warrants listed on Nasdaq under CORZ and CORZW.
Financial metrics
The filing text provided does not include revenue, profit or loss, cash flow, margins, debt, liquidity, operating statistics, or other financial metrics. Those results were discussed during the conference call, but the transcript content is not included in the provided filing text.
Material changes versus the prior comparable period
The filing does not provide a clear comparison with the prior-year or prior-period results.
Guidance, outlook, risks, and unusual items
The filing furnishes an August 11, 2022 earnings conference call transcript as Exhibit 99.1 under Regulation FD. The provided text does not include management’s guidance, outlook, commentary, identified risks, contingencies, or unusual items.
The conference call information is furnished and is not deemed filed for purposes of Section 18 of the Securities Exchange Act or incorporated by reference into other filings.
Key facts for investors to verify
- Review Exhibit 99.1 for the actual second-quarter and six-month financial results.
- Verify revenue, profitability, cash flow, cash balances, debt obligations, and liquidity.
- Assess management’s outlook, capital requirements, operating plans, and any risk disclosures in the conference call transcript.
- Confirm whether the filing’s results or commentary indicate material changes from the comparable prior period.